These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 4130537)

  • 21. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
    Raine CS
    Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
    [No Abstract]   [Full Text] [Related]  

  • 22. Cell-mediated hypersensitivity to neural antigens. Occurrence in human patients and nonhuman primates with neurological diseases.
    Behan PO; Behan WM; Feldman RG; Kies MW
    Arch Neurol; 1972 Aug; 27(2):145-52. PubMed ID: 4625188
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental allergic encephalomyelitis antigen (author's transl)].
    Nagai Y; Nakano K
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):794-9. PubMed ID: 4140545
    [No Abstract]   [Full Text] [Related]  

  • 24. Multiple sclerosis: autoimmune disease.
    Chinen A; Yokoyama M
    Hawaii Med J; 1971; 30(6):464-71. PubMed ID: 5156962
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem.
    Paterson PY; Fujinami RS; Day ED; Varitek VA; Pescovitz MD; Kelly J; Lorand L
    Trans Am Clin Climatol Assoc; 1978; 89():109-18. PubMed ID: 81557
    [No Abstract]   [Full Text] [Related]  

  • 26. Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis.
    Sheremata W; Cosgrove JB; Eylar EH
    N Engl J Med; 1974 Jul; 291(1):14-7. PubMed ID: 4598923
    [No Abstract]   [Full Text] [Related]  

  • 27. Aspects of humoral and cellular immunity in schizophrenia.
    Vartanian ME; Kolyaskina GI; Lozovsky DV; Burbaeva GS; Ignatov SA
    Birth Defects Orig Artic Ser; 1978; 14(5):339-64. PubMed ID: 80239
    [No Abstract]   [Full Text] [Related]  

  • 28. Cell-mediated hypersensitivity and disease activity in multiple sclerosis.
    Sheremata W; Cosgrove JB; Robb P
    Trans Am Neurol Assoc; 1973; 98():306-9. PubMed ID: 4784962
    [No Abstract]   [Full Text] [Related]  

  • 29. Binding of encephalitogenic basic protein by serum alpha-globulins.
    McPherson TA; Marchalonis JJ; Lennon V
    Immunology; 1970 Dec; 19(6):929-33. PubMed ID: 4098879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
    Béraud-Juven E
    Rev Prat; 1994 Jan; 44(1):69-74. PubMed ID: 8178062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-coding plasmid DNA induces IFN-gamma in vivo and suppresses autoimmune encephalomyelitis.
    Boccaccio GL; Mor F; Steinman L
    Int Immunol; 1999 Feb; 11(2):289-96. PubMed ID: 10069427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic mechanisms in experimental encephalomyelitis in nonhuman primates.
    Behan PO; Kies MW; Lisak RP; Sheremata W; Lamarche JB
    Arch Neurol; 1973 Jul; 29(1):4-9. PubMed ID: 4123120
    [No Abstract]   [Full Text] [Related]  

  • 33. Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE).
    Tutaj M; Szczepanik M
    J Autoimmun; 2007 Jun; 28(4):208-15. PubMed ID: 17442539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis.
    McKhann GM
    Annu Rev Neurosci; 1982; 5():219-39. PubMed ID: 6176172
    [No Abstract]   [Full Text] [Related]  

  • 35. [Multiple sclerosis and immunity].
    Kroda Y; Kawanami S; Kuroiwa Y
    Nihon Rinsho; 1973 Dec; 31(12):3381-6. PubMed ID: 4134071
    [No Abstract]   [Full Text] [Related]  

  • 36. Oligodendrocytes: the putative target cells of multiple sclerosis.
    Abramsky O
    Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297
    [No Abstract]   [Full Text] [Related]  

  • 37. Cellular immunity to encephalitogenic protein in multiple sclerosis. Correlations with other laboratory characteristics at different disease courses.
    Nilsson O; Thelin C
    Eur Neurol; 1977; 16(1-6):247-56. PubMed ID: 79488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural antigens and induction of myelination inhibition factor.
    Seil FJ; Kies MW; Bacon M
    J Immunol; 1975 Feb; 114(2 Pt 1):630-4. PubMed ID: 47359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Various immunobiologic properties of the serum in multiple sclerosis].
    Tsaregorodtseva TM; Chernigovskaia NV
    Biull Eksp Biol Med; 1969 Jun; 67(6):89-92. PubMed ID: 4992191
    [No Abstract]   [Full Text] [Related]  

  • 40. The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis.
    Hafler DA
    J Clin Invest; 1999 Sep; 104(5):527-9. PubMed ID: 10487765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.